Non-face-to-face Medical Platform OnDoctor "Supporting Customized Treatment for COVID-19 Aftereffects"

[Asia Economy Reporter Lee Gwan-joo] The non-face-to-face medical platform OnDoctor announced on the 27th that it will support customized treatment for COVID-19 aftereffects.

The so-called 'Long COVID syndrome' refers to COVID-19 aftereffects that occur within 3 months of onset and last for at least 2 months, with symptoms that cannot be explained by other diagnoses. It shows various symptoms such as loss of smell and taste, chronic fatigue, and decreased concentration.

According to a survey conducted by Kyungpook National University Hospital on patients who had passed 12 months after COVID-19 infection, mental aftereffects such as 'brain fog' last longer, up to one year, than physical aftereffects like fever and muscle pain. Representative symptoms include decreased concentration and cognitive function, chronic fatigue, anxiety, and depression, with recovery being particularly slower in people in their 50s.

Son Mi-young, CEO of OnDoctor, said, “There is a lack of social awareness that individuals can receive treatment and care tailored to their COVID-19 aftereffect symptoms through professional medical staff.”

OnDoctor explained that professional medical staff with extensive experience in over tens of thousands of COVID-19 treatments are responding to non-face-to-face customized treatment related to COVID-19 aftereffects. In particular, to effectively treat COVID-19 aftereffects, they are actively reviewing accumulated patient cases and overseas treatment cases while researching stable treatment methods.

The company stated, "We are leading symptom-specific COVID-19 aftereffect treatments through microbial balance regulation using probiotics, skin barrier reinforcement, capillary blood flow improvement, and recovery of nerve cell phospholipids."

This content was produced with the assistance of AI translation services.